Ch Rog News Today

By Adria Calatayud Roche Holding is scheduled to report results for 2023 on Thursday. Here is what you need to know. SALES FORECAST: The Swiss pharmaceutical...

ARK Innovation and other actively managed ETFs are having a banner year. Picking winners is as tricky as ever.

Drugmaker is doubling down on cancer and neurology as it seeks to replace falling revenue from its top sellers

Biotech deals are heating up as the year comes to an end, and analysts say the hot streak will likely continue in coming months. AbbVie and Roche Holding...

By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The...

Supreme Court case puts focus on wealth taxes, IBM and Meta form group to support open approach to AI, more pharmas seek a stake in weight-loss market, and...

The race for weight-loss drugs stepped up Monday after Roche said it would buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion.

Health-care companies ticked up amid deal activity. Swiss drug giant Roche Holding agreed to buy California-based biotechnology company Carmot Therapeutics...

Kenneth Eugene Smith would be the first person in the U.S. to be executed by nitrogen hypoxia

By Adria Calatayud Roche Holding said it received approval from the U.S. Food and Drug Administration for Vabysmo as treatment of macular edema following...